Ultrasound-Responsive Oxygen-Carrying Pollen for Enhancing Chemo-Sonodynamic Therapy of Breast Cancer

The tumor-suppressing efficacy of either chemotherapeutics or gaseous drugs has been confirmed in treating the triple negative breast cancer (TNBC), while the efficacy of single treatment is usually dissatisfactory. Herein, a novel ultrasound responsive natural pollen delivery system is presented to...

Full description

Bibliographic Details
Main Authors: Huang, D. (Author), Shan, J. (Author), Song, C. (Author), Wen, B. (Author), Zhao, Y. (Author)
Format: Article
Language:English
Published: John Wiley and Sons Inc 2023
Subjects:
Online Access:View Fulltext in Publisher
LEADER 02122nam a2200241Ia 4500
001 10.1002-advs.202300456
008 230526s2023 CNT 000 0 und d
020 |a 21983844 (ISSN) 
245 1 0 |a Ultrasound-Responsive Oxygen-Carrying Pollen for Enhancing Chemo-Sonodynamic Therapy of Breast Cancer 
260 0 |b John Wiley and Sons Inc  |c 2023 
856 |z View Fulltext in Publisher  |u https://doi.org/10.1002/advs.202300456 
520 3 |a The tumor-suppressing efficacy of either chemotherapeutics or gaseous drugs has been confirmed in treating the triple negative breast cancer (TNBC), while the efficacy of single treatment is usually dissatisfactory. Herein, a novel ultrasound responsive natural pollen delivery system is presented to simultaneously load chemotherapeutics and gaseous drugs for synergistic treatment of TNBC. The hollow structure of pollen grains carries oxygen-enriched perfluorocarbon (PFC), and the porous spinous process structure adsorbs the chemotherapeutic drug doxorubicin (DOX) (PO/D-PGs). Ultrasound can trigger the oxygen release from PFC and excite DOX, which is not only a chemotherapeutic but also a sonosensitizer, to realize chemo-sonodynamic therapy. The PO/D-PGs are demonstrated to effectively enhance oxygen concentration and increase the production of reactive oxygen species in the presence of low-intensity ultrasound, synergistically enhancing the tumor killing ability. Thus, the synergistic therapy based on ultrasound-facilitated PO/D-PGs significantly enhances the antitumor effect in the mouse TNBC model. It is believed that the proposed natural pollen cross-state microcarrier can be used as an effective strategy to enhance chemo-sonodynamic therapy for TNBC. © 2023 The Authors. Advanced Science published by Wiley-VCH GmbH. 
650 0 4 |a chemo-sonodynamic therapy 
650 0 4 |a drug delivery 
650 0 4 |a microcarrier 
650 0 4 |a oxygen carrying 
650 0 4 |a pollen 
700 1 0 |a Huang, D.  |e author 
700 1 0 |a Shan, J.  |e author 
700 1 0 |a Song, C.  |e author 
700 1 0 |a Wen, B.  |e author 
700 1 0 |a Zhao, Y.  |e author 
773 |t Advanced Science  |x 21983844 (ISSN)